loader2
Login Open ICICI 3-in-1 Account

Feb 09, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 38.70 9.06 14.56 37.69 0.04 44.95 35.66
Cipla Ltd 23.92 3.94 3.29 15.50 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 40.12 7.72 7.94 30.00 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 19.27 3.26 2.96 13.09 0.11 23.05 18.53
Lupin Ltd 23.11 4.43 5.11 19.37 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 63.19 11.74 16.01 42.05 0.50 25.84 26.46
Ipca Laboratories Ltd 43.14 4.12 4.96 25.16 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 37.34 7.78 5.26 26.48 0.04 19.52 16.16
Aurobindo Pharma Ltd 20.39 2.20 2.00 11.52 0.24 14.16 11.15
Wockhardt Ltd -450.11 7.62 5.02 80.89 0.57 3.87 -1.48
Ajanta Pharma Ltd 35.20 7.68 8.29 27.89 0.01 31.98 25.02
Gland Pharma Ltd 36.66 5.53 3.25 20.87 0.00 15.83 11.62
Biocon Ltd 79.55 3.97 1.60 21.96 0.84 6.86 6.90
Alkem Laboratories Ltd 28.51 5.30 5.15 28.06 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 52.34 4.18 5.81 31.47 0.22 18.48 15.79
Zydus Lifesciences Ltd 18.48 4.00 3.67 12.80 0.09 24.56 21.08
Divis Laboratories Ltd 65.34 17.35 10.53 53.81 0.00 20.42 15.35
Mankind Pharma Ltd 47.68 7.04 5.62 32.12 0.37 16.04 14.83
Laurus Labs Ltd 63.33 9.59 11.07 54.39 0.62 8.80 7.36
Piramal Pharma Ltd -132.40 2.37 2.68 21.85 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 69729.35
(0.9716%)
70833.65 56192.45
Nifty Bank 60669.35
(0.9128%)
61764.85 47702.90
Nifty 50 25867.30
(0.6757%)
26373.20 21743.65
Nifty 100 26487.80
(0.7244%)
26975.15 22177.35
BSE SmallCap 46825.31
(0.0%)
55792.26 41013.68
BSE Sensex 84065.75
(0.5807%)
86159.02 71425.01
BSE MidCap 44246.27
(0.0%)
47764.30 37203.21
BSE 100 27103.10
(0.7366%)
27621.72 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Suprajit Engineering fixes record date for interim dividend

Suprajit Engineering has fixed 13 February 2026 as record date for interim dividend for FY 2025-26.

Feb 09, 2026 16:52
K P R Mill fixes record date for interim dividend

K P R Mill has fixed 13 February 2026 as record date for payment of interim dividend of Rs 2.50 per equi...

Feb 09, 2026 16:50
Powergrid Infrastructure Investment Trust fixes record date for purpose of distribution

Powergrid Infrastructure Investment Trust has fixed 12 February 2026 as record date for distribution of R...

Feb 09, 2026 15:55
Procter & Gamble Health fixes record date for interim dividend

Procter & Gamble Health has fixed 12 February 2026 as record date for payment of interim dividend of Rs 1...

Feb 06, 2026 14:38
Star Cement fixes record date for 2nd interim dividend

Star Cement has fixed 12 February 2026 as record date for 2nd interim dividend of Re 1 per equity share o...

Feb 06, 2026 14:35
Cantabil Retail India fixes record date for interim dividend

Cantabil Retail India has fixed 20 February 2026 as record date for payment of interim dividend of Rs 0.7...

Feb 06, 2026 14:28
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.